Skip to content

Three-arm, cluster-randomized controlled study to assess the effects of FASTER and SCOTT trainings for adults with high-functioning autism spectrum disorder (ASD)

Three-arm, cluster-randomized controlled study to assess the effects of FASTER and SCOTT trainings for adults with high-functioning autism spectrum disorder (ASD) - FASTER/SCOTT

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017817
Enrollment
360
Registered
2020-04-20
Start date
2021-03-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F84.1 F84.0 F84.5

Interventions

Group 1: Freiburg Autism Specific Therapy for Adults (FASTER group therapy) Group 2: Social Cognition Training Tool (SCOTT&EVA, software based) Group 3: Treatment as usual (TAU)

Sponsors

Klinik für Psychiatrie und PsychotherapieUniversitätsklinikum FreiburgMedizinische Fakultät
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (+) Diagnosis of autism or Asperger syndrome, high-functioning (ICD-10: F84.0, F84.5 or F84.1 if DSM criterion A, social communication and social interaction is true) (+) Age between 18 and 65 (+) IQ at least 80 (+) Relevant psychosocial impairment [global assessment of function (GAF) score = 60] (+) Fluent German language of patient and parent / spouse / other close person to enable filling out of questionnaires and understanding instructions (+) Ability of subject to understand character and individual consequences of clinical trial (+) Written informed consent (+) No severe reading or writing disability (+) none, or stable psychopharmacotherapy (+) Existence of one person for external assessment (SRS-A, parent/ spouse/ other)

Exclusion criteria

Exclusion criteria: (-) Psychiatric comorbidities: acute (florid) psychosis, acute (florid) schizophrenia, acute bipolar disorder, acute severe depression, acute suicidality (-) substance abuse/ substance dependecies within the last 12 months (-) Present or past gambling disorder (-) Not corrected severe vision or hearing impairment (-) A history of severe group disturbing behaviour (-) Any neurological disorder or medical condition interfering with group therapy (-) Group-based social skills training or other structured psychotherapy for the core symptoms of ASD (current or in the last 6 months prior tot he study, structured psychotherapy for comorbid disorders are allowed) (-) inpatient treatment at T0

Design outcomes

Primary

MeasureTime frame
SRS-A external assessment, difference four months after randomization, after four month therapy with 16 sessions

Secondary

MeasureTime frame
(1a) Difference of change of STS-A scores between FASTER and SCOTT&EVA. (1b) Difference of change of SRS-A self-report total sum score (1c) Differences of change of SRS-A external assessment and self-report for the five subscores (1d) Differences of change of SRS-A modified for the total score and the five subscores (self-report and external assessment) (2) Changes in social cognition [MET] General psychiatric well-being [(3) depression: BDI-II, (4) global functioning: GAF, (5) social anxiety and social skills deficit: SASKO] (6) Quality of life [WHOQoL-BREF], (7) self-esteem [MSWS] and (8) life satisfaction [FLZ] (9) Partnership questionnaire, if appropriate

Countries

Germany

Contacts

Public ContactThomas Fangmeier

Universitätsklinikum Freiburg, Klinik für Psychiatrie und Psychotherapie

thomas.fangmeier@uniklinik-freiburg.de+49 761 - 270 69 680

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026